Continuous vs. Single-injection Nerve Block for Shoulder Surgery
CORA-Q15: Continuous vs. Single-injection Interscalene Block on QoR-15 in Outpatient Rotator Cuff Surgery
Recruiting
Phase 4
Interventional Study
Arthropathy Shoulder
Pain, Acute
Anesthesia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 150 (estimated)
- Sponsor
- Pontificia Universidad Catolica de Chile · Other
Who this trial is looking for
This trial is looking for adults having outpatient shoulder surgery. Participants will receive either a single injection of anesthesia or a continuous pain relief system and will provide feedback about their recovery over the next few days.
Are You a Good Fit for This Trial?
You may be able to join if
- I am an adult between 18 and 75 years old.
- I am scheduled for elective outpatient arthroscopic rotator cuff surgery.
- I can manage a continuous pain relief system.
- I have support at home.
- I live near the healthcare center.
- I am willing to provide written consent to participate.
You may not be able to join if
- I have used opioids for more than 3 months.
- I have severe health issues like kidney or liver failure.
- I am allergic to local anesthetics or dexamethasone.
- I have conditions that prevent me from having a nerve block.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of the study will be to compare the efficacy of single-injection interscalene block versus continuous interscalene block on the quality of recovery in patients undergoing outpatient arthroscopic rotator cuff repair surgery.
The participants will:
* Be randomized to receive either a single-injection interscalene block or continuous infusion via an elastomeric pump.
* Be monitored via …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults (≥18 years, \< 75 years) scheduled for elective outpatient arthroscopic rotator cuff repair surgery.
* Patients capable of managing a continuous outpatient regional analgesia system based on an interscalene block (eligibility criteria: able to understand verbal and writ…
Contacts